Drug interactions and fluoxetine: a commentary from a clinician’s perspective

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.4, Iss.6, 2005-11, pp. : 965-968

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Interactions with Lithium: A Guide for Clinicians

By Müller-Oerlinghausen B.

CNS Drugs, Vol. 11, Iss. 1, 1999-01 ,pp. : 41-48

Adis International

Access to resources Recommend Favorite

Macrocyclic Lactones and Cellular Transport-Related Drug Interactions: A Perspective from In Vitro Assays to Nematode Control in the Field

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 6, 2012-05 ,pp. : 912-923

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Aspects of the RT/drug Interactions. Perspective of Dual Inhibitors

Current Pharmaceutical Design, Vol. 19, Iss. 10, 2013-03 ,pp. : 1850-1859

Bentham Science Publishers

Access to resources Recommend Favorite

RAS/Effector Interactions from Structural and Biophysical Perspective

Mini Reviews in Medicinal Chemistry, Vol. 16, Iss. 5, 2016-03 ,pp. : 370-375

Bentham Science Publishers

Access to resources Recommend Favorite

Relative Importance of Abstinence in Clients' and Clinicians' Perspectives of Recovery from Drug and Alcohol Abuse

By Maffina Lauren Deane Frank P. Lyons Geoffrey C. B. Crowe Trevor P. Kelly Peter J.

Substance Use & Misuse, Vol. 48, Iss. 9, 2013-06 ,pp. : 683-690

Informa Healthcare

Access to resources Recommend Favorite